MFDS
- Marketing authorisation holder: ALCON
- Status: likely_approved
🇰🇷 Iophendylate in South Korea
Iophendylate (iofendylate) regulatory status in South Korea.
Marketing authorisation
Iophendylate in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in South Korea
Frequently asked questions
Is Iophendylate approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Iophendylate in South Korea?
ALCON holds the South Korean marketing authorisation.